Arctic Expedition: Uncovering Promising New Antibiotics from Deep-Sea Microbes

The frigid waters of the Arctic Ocean may conceal groundbreaking solutions to counter antibiotic resistance, researchers suggest. Recent investigations conducted during a 2020 expedition discovered that marine microbes, particularly actinobacteria, hold significant potential in developing new antibiotics. While 70% of contemporary antibiotics originate from terrestrial actinobacteria living in soil, these drugs face increasing resistance, making novel antibiotics imperative, according to the journal Frontiers in Microbiology.

The study highlights the unique capabilities of sea-dwelling actinobacteria. Due to challenging environmental pressures, including fluctuations in pressure, temperature, salinity, and light, these marine organisms produce a chemically diverse repertoire of compounds unattainable from their land-dwelling counterparts.

Researchers isolated and analyzed hundreds of unidentified compounds from actinobacteria dwelling inside marine invertebrates. They targeted enteropathogenic E. coli (EPEC), a pathogenic bacterium causing severe diarrhea, principally in children. Notably, compounds from two actinobacteria genera, Rhodococcus and Kocuria, exhibited potent antibacterial effects. The compounds thwarted EPEC from adhering to intestinal cells and obstructing their pathological mechanisms. However, only compounds from Kocuria hindered the growth of EPEC, whereas Rhodococcus made EPEC non-lethal, reducing the likelihood of resistance emergence.

According to Päivi Tammela, a pharmaceutical biology professor at the University of Helsinki, substantial research is required before commercial application is realized. Achieving large-scale production and detailed biological characterization presents formidable challenges. Despite these hurdles, researchers remain optimistic about discovering novel, clinically significant compounds in Arctic depths.

Overall, these findings spotlight an exceptional potential in marine actinobacteria, opening avenues for future antibiotic development to combat rising bacterial resistance effectively.

Earlier, SSP wrote that Earth’s rotation slowed during key life events.